The largest retrospective cohort of patients treated purely with first-line CDK4/6i + AI was ascertained from the Flatiron Health Database, which at the time of their analysis had collected information from 2 million cancer patients across 275 cancer centres in the US [18]. This evidence concerns the gene CDK4 and cancer.